Egle Therapeutics Identifies First Novel Regulatory T-cell Targets in Research Alliance with Takeda
Egle Therapeutics SAS (Egle), an emerging biotechnology company focused on developing first-in class immunotherapies targeting immune suppressor regulatory T-cells (Tregs) for oncology and autoimmune diseases, today announces that it has achieved the first milestone in its strategic research alliance with Takeda Pharmaceutical Company Limited (“Takeda”). In the course of the strategic research alliance that was announced in June 2020, Egle will validate novel tumor-infiltrating regulatory T-cell (Treg) targets against which Takeda will develop potential therapies.
Egle has leveraged its unique bioinformatic and translational capabilities to successfully identify targets that will now be pursued under the terms of the alliance. Upon achievement of the target identification, Egle will receive an R&D milestone payment and investment from Takeda.
Luc Boblet, CEO of Egle, commented “Reaching this first technical milestone marks our positive progress towards our joint goal with Takeda, of creating the next generation of differentiated immunotherapies against Tregs, and provides strong validation of the work being done at Egle. We look forward to continuing our productive alliance with Takeda while pushing further our internal programs through the equity component of the alliance.”
“We have made great progress in our collaboration with Egle and are thrilled with the speed of which we identified our first novel Treg targets,” said Loïc Vincent, Head, Oncology Drug Discovery Unit at Takeda. “We hope to build upon this momentum in the next phase of our partnership to enable and ultimately deliver new immuno-oncology therapeutic options.”
About Egle Therapeutics
Established in early 2020, as a spin-out of Institut Curie by Luc Boblet, serial biotech entrepreneur (former co-founder and CEO of PathoQuest, and former co-founder and CEO of H-Immune sold to HifiBio Therapeutics) and Dr Eliane Piaggio, PhD, renowned immunologist in the Treg / IL-2 field (INSERM Research Director, Head of the Translational Immunotherapy Team – TransImm – at Institut Curie), Egle Therapeutics is developing first-in-class immunotherapies targeting immune suppressor regulatory T cells (Tregs) for oncology and autoimmune diseases.
The key element of Egle’s core approach is the leveraging of its translational-based target discovery engine to unveil novel therapeutic Treg targets and vectorize computationally designed resurfaced cytokines acting as antagonists or as selective Treg-agonists. Egle’s flagship program pioneers dis-engagement of tumor-infiltrating Tregs through a proprietary series of IL-2 variants featuring a unique antagonism mechanism of action.
To find out more about Egle Therapeutics, please visit www.egle-tx.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201126005532/en/
Contact information
Luc Boblet
Chief Executive Officer
Email: lboblet@egle-tx.com
Images
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
KKR and Gulf Data Hub Form Strategic Partnership to Scale One of the Middle East’s Largest Independent Data Center Platforms17.1.2025 10:40:00 EET | Press release
Gulf Data Hub (“GDH” or the “Company”), one of the largest independent data center platforms in the Middle East focused on serving hyperscale demand across the Gulf countries, and KKR, a leading global investment firm, today announced that funds affiliated with KKR will acquire a stake in GDH. The investment, which is subject to customary regulatory approvals, is being made through KKR’s Global Infrastructure strategy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250117834785/en/ H.E. Dr Thani Bin Ahmed Al Zeyoudi and H.E. Omar Sultan Al Olama, presiding over the official signing of the strategic partnership between KKR and Gulf Data Hub by Tara Davies Co-Head of KKR EMEA and Co-Head of European Infrastructure and Tarek Al Ashram, CEO of Gulf Data Hub (GDH) (Photo: Business Wire) Established in 2012 and headquartered in Dubai, GDH, is one of the largest independent carrier and vendor neutral data center platforms in the Mi
Access Advance Announces Video Distribution Patent Pool in Response to Market Demand17.1.2025 01:00:00 EET | Press release
Responding to growing market demand for an industry solution for codec licensing in the video distribution market, Access Advance LLC (“Advance”) is pleased to announce the launch of its Video Distribution Patent (“VDP”) Pool. The VDP Pool will build upon the success of Advance’s existing HEVC and VVC Advance Patent Pools, which are supported by a substantial majority of video codec implementers and patent owners. It will provide a single one-stop-shop license, covering internet streaming with all four of the most recently developed video codecs (i.e., HEVC, VVC, AV1, and VP9) available today, with fixed tiered pricing scaled to the size of the video distributor’s business. This structure provides simplicity and predictability to internet video distributors, allowing them to choose which codec(s) to use based on technical and business merits rather than royalty costs or the need to negotiate multiple licenses. According to Peter Moller, CEO of Advance, “In recent years, the industry ha
CoStar Group Welcomes Bidwells as a Client, Cementing CRE Analytics Leadership in the UK16.1.2025 23:07:00 EET | Press release
CoStar Group, Inc. (NASDAQ: CSGP) (“CoStar Group,” “we” or “our”), a leading provider of online real estate marketplaces, information, and analytics in the property markets, has announced a significant new client partnership with Bidwells, a leading UK real estate advisor, specialising in science & technology, sustainability, and modern living solutions. This partnership enables Bidwells to leverage CoStar’s unrivalled commercial real estate data and analytics platform as it looks to further expand its business by tracking the market and executing strategies based on trends it identifies across multiple property sectors and regions. With access to CoStar’s extensive insights on property values, market conditions, occupancy levels, and availability, Bidwells will also enhance its ability to deliver data-driven advisory services to its clients which include many of the UK’s leading investors. “At CoStar Group, we are committed to helping our clients discover properties, gain valuable mar
FDA Authorizes All ZYN Nicotine Pouch Products Currently Marketed by Swedish Match in the U.S.16.1.2025 20:14:00 EET | Press release
The U.S. Food and Drug Administration (FDA) today authorized ZYN nicotine pouches making ZYN the first and only authorized nicotine pouch in the United States. The FDA’s authorization of all ZYN nicotine pouches currently marketed by Swedish Match in the U.S. is an important step to protect the public health by providing better alternatives to cigarettes and other traditional tobacco products for adults 21+. “An estimated 45 million Americans regularly consume nicotine and about 30 million of them smoke, the most harmful form of nicotine consumption,” said Tom Hayes, president of Swedish Match North America, LLC. “The FDA’s decision recognizes the role that ZYN can play in the protection of the public health by helping people switch from cigarettes and other traditional tobacco products.” The FDA authorized the following products: ZYN Cool Mint 3 mg ZYN Cool Mint 6 mg ZYN Peppermint 3 mg ZYN Peppermint 6 mg ZYN Spearmint 3 mg ZYN Spearmint 6 mg ZYN Wintergreen 3 mg ZYN Wintergreen 6 mg
Alvarez & Marsal Announces 2025 Managing Director Promotions16.1.2025 18:36:00 EET | Press release
Leading global professional services firm Alvarez & Marsal (A&M) has announced the promotion of 80 professionals, across Brazil, Canada, France, Germany, India, Italy, Spain, Sweden, United Arab Emirates, United Kingdom, and the United States, to the position of Managing Director. Tony Alvarez II and Bryan Marsal, A&M’s Co-Founders, stated, “All of our newly promoted Managing Directors embody the talent and leadership necessary to deliver exceptional results that create value for A&M’s clients. Their contributions to the growth of our firm and the clients we serve cannot be understated. From around the world and across our many lines of service, they exemplify A&M’s unwavering commitment to integrity, quality and objectivity, and are essential to the firm’s continued success and expansion.” Automotive & Industrials Russell Hunt, Houston Jack Kobus, Detroit Long Nguyen, Washington, D.C. Consumer & Retail Luis De Lencquesaing, New York Christopher Disa, New York Phani Mogalapu,Houston Co
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom